Abstract:
A clinical oxygen supply device (100) adapted to supply supplemental oxygen to a patient, comprising an oxygen inlet section (110) with a first coupling unit (111) adapted to be releasably coupled to a standardized oxygen wall outlet (1 ), an oxygen outlet section (120) with a second coupling unit (121 ) adapted to be releasably coupled to an oxygen dispensing device (2) attached to a patient (3), and an oxygen flow control section (130) with a regulation unit (132) adapted to regulate an oxygen flow between the oxygen inlet section (1 10) and the oxygen outlet section (120) on the basis of a control signal is provided. Display means adapted to indicate at least one operating parameter of the clinical oxygen supply device, an energy conversion section (140) adapted to generate electrical energy from pressure energy of oxygen supplied to the oxygen inlet section (1 10), and an energy supply section (150) adapted to provide the electrical energy generated by the energy conversion section (140) to the oxygen flow control section (130) and the display means are provided. The clinical oxygen supply device (100) is configured as a battery-less device. A clinical oxygen supply system (1 ) and a method of clinical oxygen supply are also part of the present invention.
Abstract:
The device is designed in particular as a dosing dispenser (2). It has an integrated electrical consumer unit (30), and a piezoelectric generator (14) for generating a very small amount of energy for energy- autonomous powering of the consumer unit (30). The dosing dispenser (2) moreover has an actuator element (26), which is movable from a starting position to an end position over an actuation stroke (H1), and moreover a control element (18) for mechanical actuation of the generator (14), which control element (18) is movable over a control stroke (H2) from a base position to an end position. Arranged between the actuator element (26) and the generator (14) is a transmission unit (28), which has the control element (18) and which is designed in such a way that the actuation stroke (H1) is decoupled from the control stroke (H2), such that only a limited stroke section of the actuation stroke (H1) is converted to the control stroke (H2). In particular, a first idle stroke (L1) is formed at the start of the actuation. The decoupling preferably takes place with the aid of an eccentric drive that comprises an eccentric unit (24).
Abstract:
A remote sensor for determining an environmental condition within pharmaceutical packaging that is inductively powered and transmits data by acoustical telemetry. The invention further includes a power supply that can also be configured to receive data from the sensor.
Abstract:
Apparatus for timed dispensing of animal care substances to animals including an electronic dispensing controller, and a dispenser operated by the electronic dispensing controller for dispensing an animal care substance to an animal at times determined by the electronic dispensing controller.
Abstract:
A powered case is provided that includes a case, configured to hold an electroactive medical device with an integrated battery; an energizing system, configured to provide electric energy; and an energy transfer system, configured to receive energy from the energizing system; and to transfer the received energy to the integrated battery of the electroactive medical device. Further, a medical device system is provided that can include an electroactive medical device, including an integrated battery; and a powered case, including a case, configured to hold the electroactive medical device with the integrated battery; an energizing system, configured to provide electric energy; and an energy transfer system, configured to receive energy from the energizing system; and to transfer the received energy to the integrated battery of the electroactive medical device.
Abstract:
An e-cigarette composition contains a solvent and from about 0.0001 to about 1 % isomyosmine (w/v). The composition may be contained in a refilling cartridge for an e-cigarette or in a receptacle of a disposable-type e-cigarette. In addition to providing a reduced-nicotine (or zero-nicotine) alternative to conventional e-liquids, the compositions yield additional benefits such as potent monoamine oxidase (MAO) inhibitory effects, which may contribute to e-cigarettes containing the compositions being particularly effective for smoking substitution, eliminating cravings for tobacco and nicotine, and transitioning individuals away from smoking or the use of other tobacco products. In some examples, e-cigarettes containing the compositions may be effective for eliminating nicotine dependence.
Abstract:
A battery management system is provided for one or more batteries. The system includes a display unit, and a controller coupled to the display unit and programmed to determine when a healthcare delivery system is coupled to the one or more batteries, to control the display unit to display an initial number corresponding to a time remaining on battery (TROB) when the healthcare delivery system is coupled to the one or more batteries, to determine if the TROB is within a reserve range extending up to a reserve range maximum, the reserve range maximum being less than a maximum TROB, to change the TROB according to an operational state of the healthcare delivery system if the TROB is greater than the reserve range maximum, and to decrease the TROB without regard for the operational state of the healthcare delivery system if the TROB is less than the reserve range maximum.
Abstract:
An electro-mechanical drug delivery device (800, 821, 850, 952) comprises a main body (802, 822, 852, 902, 956) having a distal end (808, 828, 910) and a proximal end (806, 826, 958). The distal end (808, 828, 910) is configured to attach to a dispense interface. A separable housing (804, 824, 854, 904, 962) that can prevent an administration of a drug by the drug delivery device (800, 821, 850, 952), the housing configured to cover at least a portion of the distal end (808, 828, 910) of the main body (802, 822, 852, 902, 956) when the separable housing (804, 824, 854, 904, 962) is coupled to the main body (802, 822, 852, 902, 956) of the drug delivery device (800, 821, 850, 952). A conduction element (856, 906) is provided by the main body (802, 822, 852, 902, 956) and configured for establishing an electrical connection with an electrical connector (849, 862, 968). Establishment of the electrical connection is prevented when the housing does not cover at least a portion of the distal end (808, 828, 910) of the main body (802, 822, 852, 902, 956). The electrical connection may be established when the housing covers at least a portion of the distal end (808, 828, 910) of the main body (802, 822, 852, 902, 956) of the drug delivery device (800, 821, 850, 952).
Abstract:
This invention relates to an aerosol electronic cigarette just containing nicotine without tar, which includes a shell and a suction nozzle. On the exterior wall of the shell, there is an air orifice, while there are an electronic circuit board, a constant pressure cavity, a sensor, a gasliquid separator, an atomizer, and a supplying bottle orderly located in the interior of the shell, wherein the electronic circuit board consists of an electronic switching circuit and a high-frequency generator. At one side of the sensor there is an air duct. A negative pressure cavity is located in the sensor. The atomizer connects with the supplying bottle, and there is an atomizing cavity located in the atomizer. An antiextrusion ring used to fix the supplying bottle is located between the shell and one side of the supplying bottle. At the other side of the supplying bottle there is a mirage duct. The air orifice, the constant pressure, the sensor, the gasliquid separator, the atomizer, and the mirage duct connect orderly and throughout. Without tar, this invention reduces the risk of suffering cancer, meets the requirement of the smoker, need no ignition, and has no endanger of fire.